Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Systemic Treatment of Thyroid Cancer: ASCO Guideline.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 01, 2026
Nodal T-follicular helper cell lymphoma with hodgkin/reed-sternberg-like cells: Clinicopathologic and molecular characterization of 11 cases.
Journal: Pathology, research and practice
Published: October 24, 2025
A watercress drink increases detoxification of common environmental carcinogens such as acrolein and benzene: results of a randomized clinical trial.
Journal: Carcinogenesis
Published: October 24, 2025
Ifinatamab Deruxtecan in Patients With Extensive-Stage Small Cell Lung Cancer: Primary Analysis of the Phase II IDeate-Lung01 Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 14, 2025
IDeate-Lung02: a Phase 3 study of second-line ifinatamab deruxtecan in patients with relapsed small cell lung cancer.
Journal: Future oncology (London, England)
Published: October 07, 2025
Hydroponic Growth of [13C]-Labeled Tobacco for DNA Damage Studies in Cigarette Smokers.
Journal: Journal of agricultural and food chemistry
Published: July 02, 2024
Ginsenoside 3β-O-Glc-DM (C3DM) suppressed glioma tumor growth by downregulating the EGFR/PI3K/AKT/mTOR signaling pathway and modulating the tumor microenvironment.
Journal: Toxicology and applied pharmacology
Published: October 27, 2022
PUMA overexpression dissociates thioredoxin from ASK1 to activate the JNK/BCL-2/BCL-XL pathway augmenting apoptosis in ovarian cancer.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: April 08, 2022
Structural and Functional Insights into an Archaeal Lipid Synthase.
Journal: Cell reports
Published: May 19, 2021
Structural and Functional Insights into an Archaeal Lipid Synthase.
Journal: Cell reports
Published: May 04, 2020
A Phase 1 study of gefitinib combined with durvalumab in EGFR TKI-naive patients with EGFR mutation-positive locally advanced/metastatic non-small-cell lung cancer.
Journal: British journal of cancer
Published: May 01, 2020
Last Updated: 09/26/2026